-+ 0.00%
-+ 0.00%
-+ 0.00%

TuHURA Biosciences secures $50 million credit facility, royalty deal extends cash runway into 2028

PUBT·05/15/2026 21:01:11
Listen to the news
TuHURA Biosciences secures $50 million credit facility, royalty deal extends cash runway into 2028
  • TuHURA Biosciences entered a $50 million credit facility and royalty transaction in April 2026, extending anticipated cash runway into 2028.
  • Facility allows drawdowns as needed to fund monthly operating expenses tied to clinical development and operations.
  • Borrowings carry 12% annual interest on drawn amounts, paid monthly.
  • Principal repayment due at 5-year maturity on April 21, 2031.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605151700PR_NEWS_USPR_____LA61111) on May 15, 2026, and is solely responsible for the information contained therein.